25th May 2016 08:18
LONDON (Alliance News) - Alliance Pharma PLC Wednesday said it looks forward to 2016 with confidence, as it saw revenue in line with its expectations in the first four months of the year.
In a statement ahead of its annual general meeting the specialty pharmaceutical company said its business, combined with the recently acquired Sinclair Healthcare Products business, together generated GBP30.5 million in revenue in the first four months of 2016, which was in line with its expectations.
The scar reduction product it acquired with the Sinclair portfolio, Kelo-Cote, is now its largest selling brand, making sales of GBP3.0 million in the four months.
"The key activity of combining the two organisations is underway. We are in the process of integrating the Sinclair products under the Alliance name and of aligning the operational capabilities of the enlarged company; both projects are progressing to plan," said Chairman Andrew Smith in a statement. "We look forward to the year ahead with confidence."
Shares in Alliance Pharma were up 1.3% at 47.72 pence Wednesday.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Alliance Pharma